You Are Here:Home/Resources/Quality Assurance and Performance Improvement (QAPI)/Quality Assurance and Performance Improvement (QAPI) Details
Nursing homes across the United States routinely give antipsychotic drugs to residents with dementia to control their behavior, despite rules against the misuse of drugs as “chemical restraints,” Human Rights Watch said in a report and video released today. This abusive practice remains widespread, even though the use of antipsychotic drugs on older people with dementia is associated with a nearly doubled risk of death.
The 157-page report, “‘They Want Docile’: How Nursing Homes in the United States Overmedicate People with Dementia,” estimates that every week in US nursing facilities, more than 179,000 people, mostly older and living with dementia, are given antipsychotic drugs without an appropriate diagnosis. Facilities administer these drugs in many cases without obtaining informed consent from residents or their families.
The report is based on visits by Human Rights Watch researchers to more than 100 nursing facilities in six states and more than 300 interviews with people living in facilities, their families, staff, long-term care and disability experts, government officials, and advocates.
Tools that providers can use to prepare for the Focused Dementia Care Survey.
Slides, audio recording, and transcript from the Dec. 11, 2017, CMS webinar on the MDS-based quality measure (QM) reports in the Skilled Nursing Facility Quality Reporting Program.
FDA launches new tool for sharing information that allows doctors to better manage antibiotic use; improve patient care: New website streamlines how FDA updates information used to help health care providers choose an appropriate treatment for a patient’s infection
To access this article, please login or sign up for a membership.